Important Change for Entries in EudraGMDP Database

Recommendation
25-27 March 2025
Vienna, Austria
Understand the Implications of becoming a QP
The new regulatory framework for veterinary medicinal products requires several changes to the EudraGMDP database. One important change is the integration of EudraGMDP into the EMA's Organisation Management Service (OMS).
From 28 January 2022, users of EudraGMDP from national competent authorities will no longer introduce organisational data (organisation name and location address details) directly into the relevant fields on the EudraGMDP database. Instead, they will select the relevant organisation name and location address details, including the legally registered address, of the manufacturers/importers/distributors from the Agency's organisation dictionary (so-called OMS).
It is therefore necessary that all organisations currently regulated through EudraGMDP (which appear on documents within EudraGMDP, including EU and non-EU manufacturers, importers and distributors of human and veterinary medicinal products and active substances) are registered in OMS.
For this purpose, EMA is organising a webinar (Integration of EudraGMDP and OMS - Webinar for industry).
The webinar for industry users will cover:
- Integration of EudraGMDP and OMS - implications for industry users;
- OMS services and activities;
- OMS change request process;
- customer service (EMA Service Desk)
- data quality management.
Related GMP News
17.03.2025Root Cause Analysis: Again, problems discovered in GMP-Inspections
17.03.2025ICMRA publishes Hybrid Inspection Pilot Summary Report
17.03.2025From Burkholderia to Ethylene Glycol - a List of Deficiencies at a Manufacturer of OTC Products
17.03.2025Warning Letter - Deficiencies in the Control of Raw and Starting Materials
17.03.2025Inadequate Microbiological Testing of Nonsterile Products - FDA Warning Letter
19.02.2025MRA on GMP Inspections between Switzerland and Canada extended